Premium
LAC and RTI: Eliminate Medicaid prior auth for bupe
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32422
Subject(s) - medicaid , prior authorization , buprenorphine , authorization , opioid use disorder , medicine , medical emergency , family medicine , opioid , computer security , computer science , pharmacology , political science , law , health care , receptor
Since April 2018, Medicare limited utilization management — most often done via prior authorization requirements — for buprenorphine to treat opioid use disorder (OUD). In response, virtually all plans that covered this treatment removed prior authorization requirements. Medicaid plans should do the same, according to RTI, writing in the July 9 issue of the Journal of the American Medical Association (JAMA) .